Eledon Pharmaceuticals, Inc. (ELDN) Free cash flow 2016–2017
Eledon Pharmaceuticals, Inc. (ELDN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.9MFY2017 · since FY2016: -$5.5M → -$14.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -$14.9M | -172.4% |
| FY2016 | -$5.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELDN financial trends
ELDN RevenueELDN Net incomeELDN Net marginELDN Gross profitELDN Gross marginELDN Operating incomeELDN Operating marginELDN Operating cash flowELDN Capital expendituresELDN Return on equityELDN Stock buybacksELDN Dividends paidELDN Total assetsELDN Total liabilitiesELDN Shareholders’ equityELDN overview →